본문 바로가기
  • Home

A Case of Hemoglobin Level Improvement Following Cesarean Delivery Using Ortho-Cellular Nutrition Therapy (OCNT)

  • CELLMED
  • Abbr : CellMed
  • 2026, 16(), pp.4~4
  • DOI : 10.5667/CellMed.spc.165
  • Publisher : Cellmed Orthocellular Medicine and Pharmaceutical Association
  • Research Area : Medicine and Pharmacy > General Medicine
  • Received : April 28, 2026
  • Accepted : April 30, 2026
  • Published : April 30, 2026

Jun Kyung Jang 1

1다온약국 (Daon Pharmacy)

Irregular Papers

ABSTRACT

Objective: During pregnancy, women experience various physiological changes, including an increase in plasma volume of up to 50%. Iron is essential for hemoglobin synthesis and oxygen delivery, and additional iron supplementation is required throughout pregnancy. Persistent iron deficiency increases the risk of gestational anemia and may lead to severe anemia because of considerable blood loss during delivery, particularly cesarean delivery. Blood transfusion for anemia management requires careful consideration because of concerns about adverse effects such as infection, and various alternative approaches, including iron repletion prior to delivery, have gained increasing attention. Case Report: This case report describes a Korean woman in her 30s who was found to have a hemoglobin level below the normal range on laboratory evaluation performed after cesarean delivery. The patient received Ortho-Cellular Nutrition Therapy (OCNT) using iron, folic acid, and vitamin B12. Repeat testing conducted approximately two weeks after the initial evaluation confirmed that her hemoglobin level had returned to the normal range. Conclusion: Given that this case was based on a single patient, there are limitations in applying the same OCNT regimen to other patients presenting with comparable clinical conditions and symptoms. Nonetheless, appropriately prescribed OCNT may be beneficial in maintaining and improving iron levels in pregnant women, as well as in supporting their overall health.

Citation status

* References for papers published after 2024 are currently being built.